Space and location of cerebral microbleeds, cognitive decline, and dementia in the community

Jie Ding1, Sigurður Sigurðsson1, Pálmi V Jónsson1

  • 1From the Laboratory of Epidemiology and Population Sciences (J.D., O.M., L.J.L.), National Institute on Aging, NIH, Bethesda, MD; Icelandic Heart Association (S.S., G.E., O.K., V.G.), Kopavogur; Faculty of Medicine (P.V.J., V.G.), University of Iceland, Reykjavik; Department of Psychiatry and Neurology (O.L.L.), University of Pittsburgh, Pennsylvania; and Department of Radiology (M.A.v.B.), Leiden University Medical Center, the Netherlands.

Neurology
|May 5, 2017
PubMed
Abstract

Insights

Cerebral microbleeds (CMBs) in older adults, especially those in mixed locations, are linked to faster cognitive decline and increased dementia risk. The number and location of CMBs indicate microvascular damage impacting brain health.

Area of Science:

  • Neuroimaging
  • Neurology
  • Gerontology

Background:

  • Cerebral microbleeds (CMBs) are MRI-visible indicators of microvascular damage.
  • Understanding CMBs' association with cognitive decline is crucial for aging populations.

Purpose of the Study:

  • To investigate the link between the number and location of CMBs and the onset of cognitive disease.
  • To assess CMBs' impact on cognitive domains in older adults.

Main Methods:

  • Longitudinal population-based study (AGES-Reykjavik) with 2,602 participants (66-93 years).
  • Brain MRI and cognitive testing (verbal memory, processing speed, executive function) at baseline and follow-up (mean 5.2 years).
  • Dementia cases adjudicated using international guidelines.

Main Results:

  • CMBs in deep or mixed (deep/lobar) areas correlated with greater decline across all cognitive domains.
  • Mixed CMBs strongly predicted memory and processing speed decline.
  • ≥3 CMBs were associated with steeper global cognitive, memory, and speed decline.
  • Higher CMB load (≥3) predicted increased incidence of all-cause and vascular dementia.

Conclusions:

  • A higher burden of CMBs, with location-specific effects, accelerates cognitive deterioration in older individuals.
  • Findings suggest contributions from hypertensive vasculopathy and combined hypertensive/amyloid angiopathy in cognitive decline.